| Press Release - | Orthopaedic Shoes Market to Reach USD 2,863 Million by 2028 |
Vantage Market Research | 18 Nov 2021
Healthcare
Orthopaedic Shoes Market to Reach USD 2,863 Million by 2028

According to analysts at Vantage Market Research, the Orthopaedic Shoes Market is expected to reach USD 2,863 Million by 2028, growing at a CAGR of 7.6% between 2021 and 2028.
Orthopedic shoes are particularly created for individuals who have disfigurements on the foot and ankle. It assists the muscles, tendons, and joints by appropriately adjusting their orientation. It aids to reduce pain while walking or standing. The footwear outputs are not just to offer better support but to further ensure better foot health by inhibiting several problems that would lead to pain or distress.
Key Findings:
Orthopedic shoes have different characteristics such as flexible buckles and Velcro straps which assist you to get relaxation from your feet problems like bunions, corns, and hammers thus creating a positive scope for the overall market growth.
North America is expected to record the highest CAGR, owing to the increasing demand in countries, such as the U.S., Canada, and Mexico. The added factor that is elevating the market growth is rising games and sports-related wounds, fractures, neuromuscular and musculoskeletal damage among individuals.
Some of the key players in the Orthopaedic Shoes Market include Schein Group, Aetrex Worldwide Inc., My FootDr, Chaneco, GANTER Shoes GmbH, THINNER, Happy Walker, Uvex Group, Arden Orthotics, Jane Saunders & Manning Ltd, MEPHISTO, Reed Medical Ltd.., among others. The market is comprised of a high degree of competition due to the presence of numerous key players.
Healthcare
Orthopaedic Shoes Market to Reach USD 2,863 Million by 2028
18 Nov 2021
Min Read
Access Full Report
Orthopaedic Shoes Market to Reach USD 2,863 Million by 2028
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleLatest Press Release
Contact
Toll Free Number+1 (877) 462-2282